Search - tctmd.com

Displaying 41 - 60 of 215

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1117: Comparative Outcomes of Balloon Aortic Valvuloplasty Followed by TAVR Versus Direct TAVR in Patients with Cardiogenic Shock and Severe Aortic Stenosis: A Real-World TriNetX Network Analysis

Presenter: Aditya Desai

October 27, 2025

Presentation TCT 2025

TCT 1790: Single-Session High-Risk PCI and TAVI in Severe Aortic Stenosis and Multivessel Disease

Presenter: Tamara Natasha Dijkstra

October 27, 2025

Presentation TCT 2025

TCT 1787: BAV as a Bridge to Impella-Protected Indicated High-Risk PCI in a Patient With Severe Aortic Stenosis and Calcified MVD

Presenter: Jan Roczniak

October 27, 2025

Presentation TCT 2025

TCT 1786: A 57-Year-Old Presenting With Cardiogenic Shock, Severe Ischemic Cardiomyopathy and Critical Aortic Valve Stenosis

Presenter: Adnan Alexander Kassier

October 27, 2025

Presentation TCT 2025

TCT 1153: Determining Cut-off Values of Non-dimensional Aortic Valve Coefficient (AVC) for Functional Assessment of Aortic Stenosis in TAVR Patients: A Prospective Analysis

Presenter: Shreyash Manegaonkar

October 27, 2025

Presentation TCT 2025

Lessons Learned From My Most Memorable Urgent Coronary Cases Complicated by Aortic Stenosis (or the Other Way Around)

Presenter: Corrado Tamburino

October 27, 2025

Presentation TCT 2025

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

Perspectives from TAVR UNLOAD

Presenter: Nicolas M. Van Mieghem

October 26, 2025

Presentation TCT 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Presenter: Joao L. Cavalcante

October 26, 2025

Presentation TCT 2025

Not Much, We Need Stronger Evidence!

Presenter: Sanjay Kaul

October 26, 2025

Presentation TCT 2025

Yes, Most Definitely!

Presenter: Philippe Genereux

October 26, 2025

Presentation TCT 2025

Insights into the New European Guidelines

Presenter: Michael A. Borger

October 26, 2025

Presentation TCT 2025

TCT 1129: The long-term outcomes of VitaFlow transcatheter valve system in the treatment of high surgical risk patients with severe aortic stenosis(VITAL trial)：bicuspid versus tricuspid valve

Presenter: Shasha Chen

October 26, 2025

Presentation TCT 2025

TCT 1135: Safety and efficacy of Transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type-0 bicuspid aortic valve stenosis patients

Presenter: Dejing Feng

October 26, 2025

Presentation TCT 2025

Featured Innovation: Automated Diagnosis and Classification of Aortic Stenosis from A Single Echocardiographic View: A Novel Machine Learning Approach

Presenter: Mayooran Namasivayam

October 26, 2025

Presentation TCT 2025

TCT 1140: Stent Frame Deformation of Self-Expanding TAVR in Bicuspid Aortic Stenosis and Impact on Valve Performance

Presenter: Gabriela Tirado-Conte

October 26, 2025

Presentation TCT 2025

Expanding Role of TAVI to Asymptomatic Severe Aortic Stenosis

Presenter: Philippe Genereux

October 26, 2025

Presentation TCT 2025

Management of Aortic Stenosis PLUS... Concomitant and Multivalvular Heart Disease

Presenter: Gilbert H. L. Tang

October 26, 2025

Presentation TCT 2025

Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat?

Presenter: Matthew John Czarny

October 26, 2025

Presentation TCT 2025

TCT 317: Impact of Very Severe Aortic Stenosis on Periprocedural Stroke Risk After Transcatheter Aortic Valve Replacement

Presenter: Jung-Joon Cha

October 26, 2025

Advertisement

TCT 1117: Comparative Outcomes of Balloon Aortic Valvuloplasty Followed by TAVR Versus Direct TAVR in Patients with Cardiogenic Shock and Severe Aortic Stenosis: A Real-World TriNetX Network Analysis

TCT 1790: Single-Session High-Risk PCI and TAVI in Severe Aortic Stenosis and Multivessel Disease

TCT 1787: BAV as a Bridge to Impella-Protected Indicated High-Risk PCI in a Patient With Severe Aortic Stenosis and Calcified MVD

TCT 1786: A 57-Year-Old Presenting With Cardiogenic Shock, Severe Ischemic Cardiomyopathy and Critical Aortic Valve Stenosis

TCT 1153: Determining Cut-off Values of Non-dimensional Aortic Valve Coefficient (AVC) for Functional Assessment of Aortic Stenosis in TAVR Patients: A Prospective Analysis

Lessons Learned From My Most Memorable Urgent Coronary Cases Complicated by Aortic Stenosis (or the Other Way Around)

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives from TAVR UNLOAD

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Not Much, We Need Stronger Evidence!

Yes, Most Definitely!

Insights into the New European Guidelines

TCT 1129: The long-term outcomes of VitaFlow transcatheter valve system in the treatment of high surgical risk patients with severe aortic stenosis(VITAL trial)：bicuspid versus tricuspid valve

TCT 1135: Safety and efficacy of Transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type-0 bicuspid aortic valve stenosis patients

Featured Innovation: Automated Diagnosis and Classification of Aortic Stenosis from A Single Echocardiographic View: A Novel Machine Learning Approach

TCT 1140: Stent Frame Deformation of Self-Expanding TAVR in Bicuspid Aortic Stenosis and Impact on Valve Performance

Expanding Role of TAVI to Asymptomatic Severe Aortic Stenosis

Management of Aortic Stenosis PLUS... Concomitant and Multivalvular Heart Disease

Low Flow Low Gradient Severe Aortic Stenosis: How Low Is Too Low To Treat?

TCT 317: Impact of Very Severe Aortic Stenosis on Periprocedural Stroke Risk After Transcatheter Aortic Valve Replacement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content